Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Greenleaf Ventures is a venture capital firm founded in 2000 and based in the United States. Co-founded by Timothy Stocksdale and David Wallace, the firm specializes in transforming healthcare through strategic investments and hands-on leadership. With a focus on control equity investments, Greenleaf Ventures targets early-stage and growth-focused companies in the healthcare sector.
The firm has built a notable portfolio of seven companies, demonstrating its commitment to driving sustainable growth and operational excellence. Greenleaf Ventures has a history of successful exits, including Access Diabetic Supply and Comfort Medical, showcasing its ability to identify and nurture promising healthcare businesses. The firm operates with a clear mission to enhance patient outcomes and improve healthcare delivery through its investments.
Greenleaf Ventures specializes in control equity investments in established healthcare businesses, with a strong emphasis on early-stage and growth-focused companies. The firm invests between $10 million and $50 million per opportunity, targeting sectors such as healthcare services, medical devices and supplies, specialty pharmaceuticals, healthtech, and consumer healthcare. This diverse sector focus allows Greenleaf Ventures to capitalize on various opportunities within the healthcare market.
The firm seeks to drive sustainable growth and operational excellence by providing not only capital but also resources and expertise to its portfolio companies. Greenleaf Ventures looks for founders who demonstrate a strong vision and commitment to innovation in healthcare. Their investment strategy is designed to support companies that are poised to make a significant impact in the healthcare industry.
Greenleaf Ventures has a diverse portfolio of seven companies, primarily focused on healthcare innovation. Notable portfolio companies include:
Additionally, the firm has successfully exited from several notable companies:
Timothy Stocksdale: Managing Partner and Co-Founder. Stocksdale has extensive experience in founding, scaling, and selling healthcare companies. His expertise lies in operational excellence and strategic investment.
David Wallace: Managing Partner and Co-Founder. Wallace brings a wealth of knowledge in healthcare investments and has a proven track record of driving growth in portfolio companies.
To pitch Greenleaf Ventures, founders should visit their website at greenleafventures.com. It is essential to include a comprehensive pitch deck that outlines the business model, market analysis, and financial projections. The firm prefers pitches that clearly articulate the startup's vision and how it aligns with their investment focus in healthcare.
Response times may vary, but founders should expect to hear back within a few weeks. Warm introductions are encouraged, as they can enhance the likelihood of a favorable review.
As of March 2023, Greenleaf Ventures continues to actively invest in the healthcare sector, focusing on companies that drive sustainable growth and innovation. The firm has maintained a notable portfolio, which includes companies specializing in diabetes care and medical supply distribution.
Recent activities include ongoing support for existing portfolio companies and exploring new investment opportunities within the healthcare market.
What are Greenleaf Ventures' investment criteria?
Greenleaf Ventures focuses on control equity investments in established healthcare businesses, particularly those in early-stage and growth phases. They invest between $10 million and $50 million per opportunity.
How can I apply or pitch to Greenleaf Ventures?
Founders can submit their pitches through the Greenleaf Ventures website at greenleafventures.com. It is advisable to include a detailed business plan and financial projections in the pitch deck.
What makes Greenleaf Ventures different from other investors?
The firm emphasizes hands-on leadership and operational expertise, providing not just capital but also strategic guidance to help portfolio companies achieve sustainable growth.
What is the geographic scope of Greenleaf Ventures' investments?
Greenleaf Ventures primarily invests in companies based in the United States, focusing on the healthcare sector.
What is Greenleaf Ventures' post-investment involvement like?
The firm actively engages with its portfolio companies, offering operational support and strategic guidance to drive growth and innovation.
What is the typical check size for investments?
Greenleaf Ventures typically invests between $10 million and $50 million in each opportunity, depending on the specific needs and potential of the company.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.